Tilray Brands

TLRYNasdaq United States Health Care Medicinal Chemicals and Botanical Products

Market cap

$555.711 M

$4.08 +2.26%

Close of 21 Sept 2026

Revenue

$915.5M

#1571 by revenue

Earnings

-$121.4M

Loss-making

Shares outstanding

136,203,579

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Medicinal Chemicals and Botanical Products, ranked by market cap

All 26 →

#8Cronos GroupCRON$1.23B
#9Glass House BrandsGLAS$698.7M
#10Tilray BrandsTLRY$555.7M
#11Canopy GrowthCGC$390.8M
#12Orchestra BioMedOBIO$375.7M

Insiders buying

All insider buying →

3 open-market purchases by officers and directors of Tilray Brands, worth $69.2K. Grants and option exercises are excluded.

Mitchell GendelGlobal General Counsel$11.1K
2,500 shares at $4.43 on 6 Aug 2026 · filed 7 Aug 2026
Carl A. MertonChief Financial Officer$46.2K
10,000 shares at $4.62 on 4 Aug 2026 · filed 4 Aug 2026
Denise M. FaltischekChief Strategy Officer$11.9K
2,500 shares at $4.78 on 3 Aug 2026 · filed 4 Aug 2026

What if Tilray Brands were worth as much as…

Open the what-if tool →

Gold $30.3T

$222,270.62

Per share 54,478× higher

Bitcoin $1.72T

$12,626.71

Per share 3,095× higher

Nvidia $5.48T

$40,232.85

Per share 9,861× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Tilray Brands are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.